Protedyne Corporation adds Innovative Centrifuge-Vacuum Hybrid Protocol for Molecular Diagnostics to BioCube System

Windsor, CT (PRWEB) July 26, 2005 -- Protedyne Corporation, a leading lab automation provider, today announced the availability of a centrifuge-vacuum hybrid protocol for nucleic acid extraction. The protocol is designed for use on the BioCube System, the companys advanced laboratory automation platform.

The preparation of high quality DNA samples from blood is paramount for molecular diagnostic applications. The Protedyne Centrifuge-Vacuum Hybrid Protocol combines centrifugation to clear blood lysates in membrane-based extraction protocols with downstream vacuum manifolds to manage the multiple wash steps required to achieve high purity DNA. The faster processing afforded by vacuum manifolds is indispensable for high throughput sample testing. Protedynes hybrid protocol combines this gain in efficiency with a reduction in sample failure rates resulting from the clogged wells common to vacuum-only systems.

About Protedyne

Protedynes unique approach combines scientific and automation expertise with industrial-quality automation and sophisticated data management. The foundation of the company is the BioCube System platform, which brings advanced industrial-automation capabilities into the life science laboratory in a fast, flexible, and reliable package. Protedyne is headquartered in Windsor, Connecticut, USA. For more information call +1 (860) 683-1860 or visit Protedyne on the web at www.protedyne.com.

###